Related Experiment Video
Updated: May 15, 2026

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase
Published on: June 24, 2025
Effects of familial mutations on the monomer structure of Aβ₄₂
Abstract:
Amyloid beta (Aβ) peptide plays an important role in Alzheimer's disease. A number of mutations in the Aβ sequence lead to familial Alzheimer's disease, congophilic amyloid angiopathy, or hereditary cerebral hemorrhage with amyloid. Using molecular dynamics simulations of ∼200 μs for each system, we characterize and contrast the consequences of four pathogenic mutations (Italian, Dutch, Arctic, and Iowa) for the structural ensemble of the Aβ monomer. The four familial mutations are found to have distinct consequences for the monomer structure.
Insights
Four Alzheimer's disease mutations (Italian, Dutch, Arctic, Iowa) distinctly alter amyloid beta (Aβ) monomer structure. Molecular dynamics simulations reveal unique structural consequences for each pathogenic mutation in Aβ peptides.
Area of Science:
- Neuroscience
- Biochemistry
- Computational Biology
Background:
- Alzheimer's disease is linked to amyloid beta (Aβ) peptide aggregation.
- Familial Alzheimer's disease, congophilic amyloid angiopathy, and hereditary cerebral hemorrhage with amyloid are associated with specific Aβ mutations.
- Understanding Aβ monomer structure is crucial for Alzheimer's disease pathogenesis.
Discussion:
- This study utilized extensive molecular dynamics (MD) simulations (∼200 μs per system) to analyze Aβ monomer structural ensembles.
- The research focused on four pathogenic mutations: Italian, Dutch, Arctic, and Iowa.
- The simulations provided detailed insights into how these specific mutations affect the Aβ monomer's structural dynamics.
Key Insights:
- Each of the four familial mutations (Italian, Dutch, Arctic, Iowa) exerts unique effects on the Aβ monomer's structure.
- The structural consequences of these mutations are distinct, highlighting mutation-specific pathogenic mechanisms.
- This detailed characterization of monomer structure provides a foundation for understanding downstream aggregation events.
Outlook:
- Further research can explore how these distinct monomer structures influence Aβ fibril formation and toxicity.
- Investigating therapeutic strategies targeting specific mutation-induced structural changes in Aβ monomers is warranted.
- These findings contribute to a deeper understanding of the molecular basis of various amyloidogenic diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Alzheimer Disease ll: Pathophysiology
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

